| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Ge Liu | |
| Qinchang Zhu | |||
| Masaaki Kai | |||
| P2860 | cites work | Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA. | Q44432574 |
| Enzyme-linked small-molecule detection using split aptamer ligation | Q48153423 | ||
| Development of a fluorescent enzyme-linked DNA aptamer-magnetic bead sandwich assay and portable fluorometer for sensitive and rapid leishmania detection in sandflies. | Q50483529 | ||
| Screening of DNA aptamers against myoglobin using a positive and negative selection units integrated microfluidic chip and its biosensing application. | Q51075610 | ||
| Aptamers as therapeutics. | Q51813594 | ||
| In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection | Q56902246 | ||
| Affinity analysis of DNA aptamer-peptide interactions using gold nanoparticles | Q83169956 | ||
| Sensitive point-of-care monitoring of cardiac biomarker myoglobin using aptamer and ubiquitous personal glucose meter | Q85301777 | ||
| Cell-SELEX based selection and characterization of DNA aptamer recognizing human hepatocarcinoma | Q86101126 | ||
| Structural basis for discriminatory recognition of Plasmodium lactate dehydrogenase by a DNA aptamer | Q27679972 | ||
| Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase | Q27860794 | ||
| In vitro selection of RNA molecules that bind specific ligands | Q27861109 | ||
| Selection of DNA aptamers against glioblastoma cells with high affinity and specificity | Q28484184 | ||
| Development of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX method | Q28485460 | ||
| Single-Stranded DNA Aptamers against Pathogens and Toxins: Identification and Biosensing Applications | Q30406535 | ||
| DNA Aptamer Technology for Personalized Medicine | Q30412965 | ||
| DNA-aptamer targeting vimentin for tumor therapy in vivo. | Q30415521 | ||
| Aptamer in bioanalytical applications. | Q30466572 | ||
| Design strategies for aptamer-based biosensors | Q30469779 | ||
| Aptamers and their biological applications | Q30470240 | ||
| Chemically modified nucleic acid aptamers for in vitro selections: evolving evolution | Q30903585 | ||
| Influence of the 2'-hydroxyl group conformation on the stability of A-form helices in RNA. | Q31027558 | ||
| Effect of 3'-end capping of aptamer with various 2',4'-bridged nucleotides: Enzymatic post-modification toward a practical use of polyclonal aptamers | Q38346492 | ||
| ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent | Q38353688 | ||
| Structure-Switching Signaling Aptamers | Q38355518 | ||
| Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells | Q38356248 | ||
| Array-based evolution of DNA aptamers allows modelling of an explicit sequence-fitness landscape | Q38358691 | ||
| Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation. | Q38366753 | ||
| Outlook for aptamers after twenty five years | Q38440811 | ||
| A Highlight of Recent Advances in Aptamer Technology and Its Application | Q38541697 | ||
| DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics. | Q38989650 | ||
| A Cell-based Single-stranded DNA Aptamer Specifically Targets Gastric Cancer | Q39025264 | ||
| Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo | Q39128974 | ||
| Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation | Q39239168 | ||
| Simple PEG modification of DNA aptamer based on copper ion coordination for tumor targeting | Q39682746 | ||
| Synthesis and properties of mirror-image DNA | Q40422935 | ||
| A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin | Q31111010 | ||
| Novel combinatorial selection of phosphorothioate oligonucleotide aptamers | Q31960296 | ||
| DNA aptamers against the MUC1 tumour marker: design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours | Q33293976 | ||
| Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method | Q33313271 | ||
| A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura | Q33396658 | ||
| DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells | Q33591381 | ||
| DNA aptamer evolved by cell-SELEX for recognition of prostate cancer | Q33793416 | ||
| Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy | Q33834772 | ||
| In vitro selection of functional nucleic acids | Q33953593 | ||
| Probing high affinity sequences of DNA aptamer against VEGF165 | Q34168165 | ||
| Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis. | Q34326301 | ||
| Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development | Q34332193 | ||
| Rapid one-step selection method for generating nucleic acid aptamers: development of a DNA aptamer against α-bungarotoxin | Q34364189 | ||
| Pegaptanib (Macugen): treating neovascular age-related macular degeneration and current role in clinical practice. | Q34560799 | ||
| A DNA aptamer with high affinity and specificity for molecular recognition and targeting therapy of gastric cancer | Q34565529 | ||
| Selection of single-stranded DNA molecules that bind and inhibit human thrombin | Q34616171 | ||
| Selection and characterization of DNA aptamers for use in detection of avian influenza virus H5N1. | Q34633259 | ||
| Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth | Q34695253 | ||
| A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia | Q34723932 | ||
| Development of an efficient targeted cell-SELEX procedure for DNA aptamer reagents | Q34964507 | ||
| DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro. | Q35059032 | ||
| In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging. | Q35180688 | ||
| Thrombin, inflammation, and cardiovascular disease: an epidemiologic perspective | Q35217275 | ||
| Selection of LNA-containing DNA aptamers against recombinant human CD73. | Q35568409 | ||
| Aptamers overview: selection, features and applications | Q35599983 | ||
| A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery | Q35605916 | ||
| Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX. | Q35621766 | ||
| Single-Round Patterned DNA Library Microarray Aptamer Lead Identification | Q35657036 | ||
| DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition | Q35686260 | ||
| Cell-SELEX based selection and optimization of DNA aptamers for specific recognition of human cholangiocarcinoma QBC-939 cells. | Q35693567 | ||
| Applications of aptasensors in clinical diagnostics | Q35831331 | ||
| A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma | Q36028980 | ||
| Building oligonucleotide therapeutics using non-natural chemistries | Q36627400 | ||
| The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine | Q36675591 | ||
| Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages | Q37065549 | ||
| Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells in Vitro and in Vivo. | Q37240103 | ||
| Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis | Q37319748 | ||
| RNA conformational classes | Q37519987 | ||
| Emerging pharmacologic therapies for wet age-related macular degeneration | Q37558041 | ||
| Application of locked nucleic acids to improve aptamer in vivo stability and targeting function | Q37619467 | ||
| AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia. | Q37689055 | ||
| Automated modular synthesis of aptamer-drug conjugates for targeted drug delivery. | Q37700995 | ||
| Aptamer-based molecular recognition for biosensor development. | Q37774275 | ||
| Molecular evolution of functional nucleic acids with chemical modifications | Q37780443 | ||
| Improving the stability of aptamers by chemical modification | Q37916666 | ||
| Aptamer-conjugated nanomaterials and their applications | Q37948000 | ||
| Single-stranded DNA (ssDNA) production in DNA aptamer generation | Q37982285 | ||
| Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy | Q38115387 | ||
| Aptamer-based biosensors for biomedical diagnostics | Q38204726 | ||
| Aptamer binding assays for proteins: the thrombin example--a review. | Q38226959 | ||
| Oligonucleotide aptamers: new tools for targeted cancer therapy | Q38237132 | ||
| In vitro Selection of DNA Aptamers to Glioblastoma Multiforme. | Q38274697 | ||
| Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins | Q38291515 | ||
| The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells | Q38292167 | ||
| Post-SELEX chemical optimization of a trypanosome-specific RNA aptamer | Q38294223 | ||
| Evolution of DNA aptamers through in vitro metastatic-cell-based systematic evolution of ligands by exponential enrichment for metastatic cancer recognition and imaging | Q38299818 | ||
| RNA aptamers as genetic control devices: the potential of riboswitches as synthetic elements for regulating gene expression | Q38301085 | ||
| An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance. | Q38301354 | ||
| Magnetic-assisted rapid aptamer selection (MARAS) for generating high-affinity DNA aptamer using rotating magnetic fields | Q38307210 | ||
| Target-induced conjunction of split aptamer fragments and assembly with a water-soluble conjugated polymer for improved protein detection. | Q38309039 | ||
| A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection. | Q38314236 | ||
| In silico maturation of binding-specificity of DNA aptamers against Proteus mirabilis | Q38316483 | ||
| Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture | Q38317170 | ||
| Label-free detection of prion protein with its DNA aptamer through the formation of T-Hg2+-T configuration | Q38323293 | ||
| Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures | Q38330348 | ||
| Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery | Q38333122 | ||
| The von Willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy: a randomized trial | Q38334013 | ||
| Structure-switching signaling aptamers: transducing molecular recognition into fluorescence signaling | Q38342545 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nucleotide aptamers | Q49849144 |
| neoplasm | Q1216998 | ||
| drug delivery system | Q64829245 | ||
| P304 | page(s) | 20979-20997 | |
| P577 | publication date | 2015-11-25 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | DNA Aptamers in the Diagnosis and Treatment of Human Diseases | |
| P478 | volume | 20 |
| Q92703795 | Biomedical Application of Electroactive Polymers in Electrochemical Sensors: A Review |
| Q60949418 | DNA Aptamers for the Functionalisation of DNA Origami Nanostructures |
| Q52669903 | Design of Modular G-quadruplex Ligands. |
| Q39385781 | Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells |
| Q99544596 | Paper-based fluorogenic RNA aptamer sensors for label-free detection of small molecules |
| Q89968185 | Post-SELEX Optimization and Characterization of a Prostate Cancer Cell-Specific Aptamer for Diagnosis |
| Q92152187 | Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes |
Search more.